Literature DB >> 2938615

Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline.

P T Bladon, B M Burke, W J Cunliffe, R A Forster, K T Holland, K King.   

Abstract

Topical azelaic acid and oral tetracycline were compared in a 6-month double-blind study for treatment of acne vulgaris in 45 male subjects with clinical acne. Their acne was graded, inflamed or non-inflamed, lesions were counted and the density of their skin microflora was measured. Both treatments were of benefit and produced only a few minor side-effects. Although oral tetracycline was more effective than azelaic acid, the differences were only just significant. The average reduction in numbers of cutaneous micrococcaceae and Propionibacterium sp. with azelaic acid treatment was 224 and 30-fold, respectively. In a separate group of 11 male subjects with physiological acne the effect of azelaic acid on sebum excretion rate was assessed, and little change was detected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938615     DOI: 10.1111/j.1365-2133.1986.tb02856.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

Review 1.  Current views on the aetiology, pathogenesis and treatment of acne vulgaris.

Authors:  L Lever; R Marks
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Gene expression profile of high-fat diet-fed C57BL/6J mice: in search of potential role of azelaic acid.

Authors:  Shanmugam Muthulakshmi; Alok K Chakrabarti; Sanjay Mukherjee
Journal:  J Physiol Biochem       Date:  2015-01-11       Impact factor: 4.158

4.  Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases.

Authors:  H Akamatsu; J Komura; Y Asada; Y Miyachi; Y Niwa
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 5.  Transdermal penetration of topical drugs used in the treatment of acne.

Authors:  Andrea Krautheim; Harald Gollnick
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.

Authors:  Mark A T Blaskovich; Alysha G Elliott; Angela M Kavanagh; Soumya Ramu; Matthew A Cooper
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

7.  Activation of ectopic olfactory receptor 544 induces GLP-1 secretion and regulates gut inflammation.

Authors:  Chunyan Wu; Mi-Young Jeong; Jung Yeon Kim; Giljae Lee; Ji-Sun Kim; Yu Eun Cheong; Hyena Kang; Chung Hwan Cho; Jimin Kim; Min Kyung Park; You Kyoung Shin; Kyoung Heon Kim; Geun Hee Seol; Seung Hoi Koo; GwangPyo Ko; Sung-Joon Lee
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  Influence of azelaic and mandelic acid peels on sebum secretion in ageing women.

Authors:  Aneta Wójcik; Marlena Kubiak; Helena Rotsztejn
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

9.  Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation.

Authors:  Stanislaw Han; Katarzyna Karlowicz-Bodalska; Dorota Szura; Lukasz Ozimek; Witold Musial
Journal:  ScientificWorldJournal       Date:  2013-10-08

10.  Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS.

Authors:  Stanisław Han; Katarzyna Karłowicz-Bodalska; Piotr Potaczek; Adam Wójcik; Lukasz Ozimek; Dorota Szura; Witold Musiał
Journal:  AAPS PharmSciTech       Date:  2013-10-29       Impact factor: 3.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.